Our results help in better understanding the role of GDCA/S1PR2/ZBP1/p-MLKL mediated macrophage necroptosis in cholestatic liver diseases, and might provide novel therapeutic strategies to attenuate BA liver fibrosis. Here, S1PR2 is linked to Cholestatic liver disease.